{"ticker": "AQXP", "overview": {"cik": "1404644", "ticker": "NGNE", "name": "Neurogene Inc.", "industry": "Pharmaceutical Preparations", "country": "United States", "sic": "2834", "announcements": [{"form": "SCHEDULE 13G", "date": "2026-10-07", "title": "Form SCHEDULE 13G", "accession": "0001137774-26-000205", "price_sensitive": false}, {"form": "SCHEDULE 13G", "date": "2026-10-06", "title": "Form SCHEDULE 13G", "accession": "0000053417-26-000058", "price_sensitive": false}, {"form": "4", "date": "2026-10-02", "title": "FORM 4", "accession": "0001606302-26-000007", "price_sensitive": false}, {"form": "SCHEDULE 13G/A", "date": "2026-08-14", "title": "Form SCHEDULE 13G/A", "accession": "0001104659-26-097193", "price_sensitive": false}, {"form": "SCHEDULE 13G/A", "date": "2026-08-14", "title": "Form SCHEDULE 13G/A", "accession": "0001493152-26-038383", "price_sensitive": false}, {"form": "SCHEDULE 13G", "date": "2026-08-14", "title": "Form SCHEDULE 13G", "accession": "0001172661-26-003430", "price_sensitive": false}, {"form": "10-Q", "date": "2026-08-11", "title": "Quarterly report", "accession": "0001404644-26-000059", "price_sensitive": true}, {"form": "8-K", "date": "2026-08-11", "title": "Material event", "accession": "0001404644-26-000056", "price_sensitive": true}, {"form": "4", "date": "2026-07-07", "title": "FORM 4", "accession": "0001543663-26-000017", "price_sensitive": false}, {"form": "4", "date": "2026-07-02", "title": "FORM 4", "accession": "0001543663-26-000015", "price_sensitive": false}, {"form": "8-K", "date": "2026-07-02", "title": "Material event", "accession": "0001404644-26-000050", "price_sensitive": true}, {"form": "424B5", "date": "2026-07-02", "title": "Prospectus", "accession": "0001628280-26-046666", "price_sensitive": false}, {"form": "424B5", "date": "2026-06-30", "title": "Prospectus", "accession": "0001628280-26-046237", "price_sensitive": false}, {"form": "8-K", "date": "2026-06-29", "title": "Material event", "accession": "0001404644-26-000046", "price_sensitive": true}, {"form": "4/A", "date": "2026-06-16", "title": "FORM 4/A", "accession": "0001996804-26-000011", "price_sensitive": false}, {"form": "4/A", "date": "2026-06-16", "title": "FORM 4/A", "accession": "0001996804-26-000010", "price_sensitive": false}, {"form": "4/A", "date": "2026-06-16", "title": "FORM 4/A", "accession": "0001996804-26-000009", "price_sensitive": false}, {"form": "3/A", "date": "2026-06-16", "title": "FORM 3/A", "accession": "0001996804-26-000008", "price_sensitive": false}, {"form": "8-K", "date": "2026-06-08", "title": "Material event", "accession": "0001404644-26-000044", "price_sensitive": true}, {"form": "8-K", "date": "2026-06-04", "title": "Material event", "accession": "0001404644-26-000040", "price_sensitive": true}, {"form": "8-K", "date": "2026-05-12", "title": "Material event", "accession": "0001404644-26-000038", "price_sensitive": true}, {"form": "10-Q", "date": "2026-05-12", "title": "Quarterly report", "accession": "0001404644-26-000037", "price_sensitive": true}, {"form": "4", "date": "2026-05-08", "title": "FORM 4", "accession": "0001543663-26-000013", "price_sensitive": false}, {"form": "4", "date": "2026-05-07", "title": "FORM 4", "accession": "0001934412-26-000006", "price_sensitive": false}, {"form": "144", "date": "2026-05-06", "title": "Notice of proposed sale", "accession": "0001968582-26-000406", "price_sensitive": false}]}, "description": "AQXP trades as AQXP. Privy Trades holds 90 insider filings for the company, from March 2014 to August 2019. Across those, 8 insiders disclosed 13 open-market purchases totalling $97.03M against 14 sales totalling $42.70M. The most recent filing on record is dated 7 August 2019.", "exchange": null, "stats": {"buy_n": 13, "buy_sum": 97025382.6315, "sell_n": 14, "sell_sum": 42702498.8523, "net": 54322883.7792, "insiders": 8, "first_date": "2014-03-12", "last_date": "2019-08-07"}, "metrics": {"ticker": "AQXP", "has_prices": false}, "trades": [{"id": "0001638599-19-000703", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "Baker BROS. Advisors LP", "who_key": "BAKER BROS. ADVISORS LP", "role": "Director, 10% Owner", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 1115615.46, "score": 51.9, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Board insider adds $1.1M of AQXP", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000163859919000703/0001638599-19-000703-index.htm", "trade_date": "2019-08-07", "timestamp": "2019-08-07", "mins": 3808370}, {"id": "0001209191-18-046094", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "Kamran Alam", "who_key": "Alam Kamran", "role": "CFO, Vice President Finance", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CFO files routine paperwork on AQXP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919118046094/0001209191-18-046094-index.htm", "trade_date": "2018-08-07", "timestamp": "2018-08-07", "mins": 4333970}, {"id": "0001209191-18-046095", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "Lloyd MacKenzie", "who_key": "MacKenzie Lloyd", "role": "Chief Operating Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "C-suite exec files routine paperwork on AQXP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919118046095/0001209191-18-046095-index.htm", "trade_date": "2018-08-07", "timestamp": "2018-08-07", "mins": 4333970}, {"id": "0001209191-18-046097", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "Shelley McCloskey", "who_key": "McCloskey Shelley", "role": "VP, HR and Administration", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Insider files routine paperwork on AQXP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919118046097/0001209191-18-046097-index.htm", "trade_date": "2018-08-07", "timestamp": "2018-08-07", "mins": 4333970}, {"id": "0001209191-18-046098", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "David Main", "who_key": "Main David", "role": "President and CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on AQXP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919118046098/0001209191-18-046098-index.htm", "trade_date": "2018-08-07", "timestamp": "2018-08-07", "mins": 4333970}, {"id": "0001209191-18-030711", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "Daniel J. Levitt", "who_key": "LEVITT DANIEL J", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "SELL", "amount": 49489.02, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Board member offloads $49K of AQXP", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919118030711/0001209191-18-030711-index.htm", "trade_date": "2018-05-14", "timestamp": "2018-05-14", "mins": 4456370}, {"id": "0001638599-18-000485", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "Baker BROS. Advisors LP", "who_key": "BAKER BROS. ADVISORS LP", "role": "Director, 10% Owner", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on AQXP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000163859918000485/0001638599-18-000485-index.htm", "trade_date": "2018-05-07", "timestamp": "2018-05-07", "mins": 4466450}, {"id": "0001209191-18-028968", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "Daniel J. Levitt", "who_key": "LEVITT DANIEL J", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on AQXP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919118028968/0001209191-18-028968-index.htm", "trade_date": "2018-05-07", "timestamp": "2018-05-07", "mins": 4466450}, {"id": "0001209191-18-028979", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "Gary Bridger", "who_key": "Bridger Gary", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on AQXP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919118028979/0001209191-18-028979-index.htm", "trade_date": "2018-05-07", "timestamp": "2018-05-07", "mins": 4466450}, {"id": "0001209191-18-028983", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "Robert Pelzer", "who_key": "Pelzer Robert", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on AQXP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919118028983/0001209191-18-028983-index.htm", "trade_date": "2018-05-07", "timestamp": "2018-05-07", "mins": 4466450}, {"id": "0001209191-18-028988", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "Todd E. Simpson", "who_key": "SIMPSON TODD E", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on AQXP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919118028988/0001209191-18-028988-index.htm", "trade_date": "2018-05-07", "timestamp": "2018-05-07", "mins": 4466450}, {"id": "0001209191-18-020680", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "Lloyd MacKenzie", "who_key": "MacKenzie Lloyd", "role": "Chief Operating Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "SELL", "amount": 19048.7808, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "C-suite trims AQXP: $19K", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919118020680/0001209191-18-020680-index.htm", "trade_date": "2018-03-15", "timestamp": "2018-03-15", "mins": 4542770}, {"id": "0001209191-18-019255", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "Kamran Alam", "who_key": "Alam Kamran", "role": "CFO, Vice President Finance", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CFO files routine paperwork on AQXP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919118019255/0001209191-18-019255-index.htm", "trade_date": "2018-03-09", "timestamp": "2018-03-09", "mins": 4551410}, {"id": "0001209191-18-019256", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "Abigail Jenkins", "who_key": "Jenkins Abigail", "role": "Chief Commercial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "C-suite exec files routine paperwork on AQXP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919118019256/0001209191-18-019256-index.htm", "trade_date": "2018-03-09", "timestamp": "2018-03-09", "mins": 4551410}, {"id": "0001209191-18-019258", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "Lloyd MacKenzie", "who_key": "MacKenzie Lloyd", "role": "Chief Operating Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "C-suite exec files routine paperwork on AQXP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919118019258/0001209191-18-019258-index.htm", "trade_date": "2018-03-09", "timestamp": "2018-03-09", "mins": 4551410}, {"id": "0001209191-18-019259", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "David Main", "who_key": "Main David", "role": "President and CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on AQXP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919118019259/0001209191-18-019259-index.htm", "trade_date": "2018-03-09", "timestamp": "2018-03-09", "mins": 4551410}, {"id": "0001209191-18-019260", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "Shelley McCloskey", "who_key": "McCloskey Shelley", "role": "VP, HR and Administration", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Insider files routine paperwork on AQXP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919118019260/0001209191-18-019260-index.htm", "trade_date": "2018-03-09", "timestamp": "2018-03-09", "mins": 4551410}, {"id": "0001209191-18-019267", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "Barbara Troupin", "who_key": "Troupin Barbara", "role": "Chief Medical Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "C-suite exec files routine paperwork on AQXP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919118019267/0001209191-18-019267-index.htm", "trade_date": "2018-03-09", "timestamp": "2018-03-09", "mins": 4551410}, {"id": "0001209191-17-037966", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "David Main", "who_key": "Main David", "role": "President and CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "SELL", "amount": 207243.7375, "score": 0.0, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO sells $207K of AQXP", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919117037966/0001209191-17-037966-index.htm", "trade_date": "2017-06-05", "timestamp": "2017-06-05", "mins": 4950290}, {"id": "0001638599-17-000427", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "Baker BROS. Advisors LP", "who_key": "BAKER BROS. ADVISORS LP", "role": "Director, 10% Owner", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on AQXP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000163859917000427/0001638599-17-000427-index.htm", "trade_date": "2017-05-08", "timestamp": "2017-05-08", "mins": 4990610}, {"id": "0001209191-17-031395", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "Gary Bridger", "who_key": "Bridger Gary", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on AQXP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919117031395/0001209191-17-031395-index.htm", "trade_date": "2017-05-08", "timestamp": "2017-05-08", "mins": 4990610}, {"id": "0001209191-17-031397", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "Daniel J. Levitt", "who_key": "LEVITT DANIEL J", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on AQXP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919117031397/0001209191-17-031397-index.htm", "trade_date": "2017-05-08", "timestamp": "2017-05-08", "mins": 4990610}, {"id": "0001209191-17-031399", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "Robert Pelzer", "who_key": "Pelzer Robert", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on AQXP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919117031399/0001209191-17-031399-index.htm", "trade_date": "2017-05-08", "timestamp": "2017-05-08", "mins": 4990610}, {"id": "0001209191-17-031405", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "Sean P. Nolan", "who_key": "Nolan Sean P.", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on AQXP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919117031405/0001209191-17-031405-index.htm", "trade_date": "2017-05-08", "timestamp": "2017-05-08", "mins": 4990610}, {"id": "0001209191-17-031406", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "Todd E. Simpson", "who_key": "SIMPSON TODD E", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on AQXP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919117031406/0001209191-17-031406-index.htm", "trade_date": "2017-05-08", "timestamp": "2017-05-08", "mins": 4990610}, {"id": "0001209191-17-020007", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "Kamran Alam", "who_key": "Alam Kamran", "role": "CFO, Vice President Finance", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CFO files routine paperwork on AQXP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919117020007/0001209191-17-020007-index.htm", "trade_date": "2017-03-08", "timestamp": "2017-03-08", "mins": 5078450}, {"id": "0001209191-17-020008", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "Abigail Jenkins", "who_key": "Jenkins Abigail", "role": "Chief Commercial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "C-suite exec files routine paperwork on AQXP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919117020008/0001209191-17-020008-index.htm", "trade_date": "2017-03-08", "timestamp": "2017-03-08", "mins": 5078450}, {"id": "0001209191-17-020009", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "Lloyd MacKenzie", "who_key": "MacKenzie Lloyd", "role": "VP Technical Operations", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Insider files routine paperwork on AQXP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919117020009/0001209191-17-020009-index.htm", "trade_date": "2017-03-08", "timestamp": "2017-03-08", "mins": 5078450}, {"id": "0001209191-17-020011", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "David Main", "who_key": "Main David", "role": "President and CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on AQXP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919117020011/0001209191-17-020011-index.htm", "trade_date": "2017-03-08", "timestamp": "2017-03-08", "mins": 5078450}, {"id": "0001209191-17-020012", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "Shelley McCloskey", "who_key": "McCloskey Shelley", "role": "VP, HR and Administration", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Insider files routine paperwork on AQXP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919117020012/0001209191-17-020012-index.htm", "trade_date": "2017-03-08", "timestamp": "2017-03-08", "mins": 5078450}], "recent_buys": [{"id": "0001638599-19-000703", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "Baker BROS. Advisors LP", "who_key": "BAKER BROS. ADVISORS LP", "role": "Director, 10% Owner", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 1115615.46, "score": 51.9, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Board insider adds $1.1M of AQXP", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000163859919000703/0001638599-19-000703-index.htm", "trade_date": "2019-08-07", "timestamp": "2019-08-07", "mins": 3808370}, {"id": "0001638599-17-000050", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "Baker BROS. Advisors LP", "who_key": "BAKER BROS. ADVISORS LP", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 6836812.6597, "score": 58.9, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "3 insiders pile into AQXP", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000163859917000050/0001638599-17-000050-index.htm", "trade_date": "2017-01-09", "timestamp": "2017-01-09", "mins": 5161970}, {"id": "0001638599-16-001421", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "Baker BROS. Advisors LP", "who_key": "BAKER BROS. ADVISORS LP", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 34110452.485, "score": 72.3, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Insider cluster: 3 buying AQXP", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000163859916001421/0001638599-16-001421-index.htm", "trade_date": "2016-09-20", "timestamp": "2016-09-20", "mins": 5321810}, {"id": "0001638599-16-000744", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "Baker BROS. Advisors LP", "who_key": "BAKER BROS. ADVISORS LP", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 3770636.3501000004, "score": 55.8, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "3 insiders pile into AQXP", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000163859916000744/0001638599-16-000744-index.htm", "trade_date": "2016-03-16", "timestamp": "2016-03-16", "mins": 5592530}, {"id": "0001144204-16-077069", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "Baker BROS. Advisors LP", "who_key": "BAKER BROS. ADVISORS LP", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 1520909.2058, "score": 50.8, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "That makes 3 insiders into AQXP", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000114420416077069/0001144204-16-077069-index.htm", "trade_date": "2016-01-26", "timestamp": "2016-01-26", "mins": 5664530}, {"id": "0001144204-16-076372", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "Baker BROS. Advisors LP", "who_key": "BAKER BROS. ADVISORS LP", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 1773653.4368999999, "score": 51.6, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Insider cluster: 3 buying AQXP", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000114420416076372/0001144204-16-076372-index.htm", "trade_date": "2016-01-20", "timestamp": "2016-01-20", "mins": 5673170}, {"id": "0001144204-16-075880", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "Baker BROS. Advisors LP", "who_key": "BAKER BROS. ADVISORS LP", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 1677083.142, "score": 51.4, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Insider cluster: 3 buying AQXP", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000114420416075880/0001144204-16-075880-index.htm", "trade_date": "2016-01-15", "timestamp": "2016-01-15", "mins": 5680370}, {"id": "0001144204-16-075875", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "Baker BROS. Advisors LP", "who_key": "BAKER BROS. ADVISORS LP", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 1677083.142, "score": 51.4, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Insider cluster: 3 buying AQXP", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000114420416075875/0001144204-16-075875-index.htm", "trade_date": "2016-01-15", "timestamp": "2016-01-15", "mins": 5680370}, {"id": "0001144204-15-054640", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "Baker BROS. Advisors LP", "who_key": "BAKER BROS. ADVISORS LP", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 38440496.0, "score": 76.2, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "AQXP draws its 3th insider buyer", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000114420415054640/0001144204-15-054640-index.htm", "trade_date": "2015-09-10", "timestamp": "2015-09-10", "mins": 5863250}, {"id": "0001209191-15-068028", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "David Chilton Mitchell", "who_key": "Mitchell David Chilton", "role": "VP Global Regulatory & Quality", "person_type": "EXEC", "person_label": "Execs", "action": "BUY", "amount": 63670.74999999999, "score": 31.7, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "3 insiders pile into AQXP", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919115068028/0001209191-15-068028-index.htm", "trade_date": "2015-08-24", "timestamp": "2015-08-24", "mins": 5887730}, {"id": "0001209191-15-065926", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "David Chilton Mitchell", "who_key": "Mitchell David Chilton", "role": "VP Global Regulatory & Quality", "person_type": "EXEC", "person_label": "Execs", "action": "BUY", "amount": 38976.0, "score": 29.2, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "AQXP draws its 4th insider buyer", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919115065926/0001209191-15-065926-index.htm", "trade_date": "2015-08-11", "timestamp": "2015-08-11", "mins": 5906450}, {"id": "0000904454-15-000039", "src": "INSIDERS", "ticker": "AQXP", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "AQUINOX PHARMACEUTICALS, INC", "who": "& Johnson Johnson", "who_key": "JOHNSON & JOHNSON", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 2999997.0, "score": 57.2, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "$3M bet: A 10% owner buys AQXP", "source_url": "https://www.sec.gov/Archives/edgar/data/200406/000090445415000039/0000904454-15-000039-index.htm", "trade_date": "2014-03-12", "timestamp": "2014-03-12", "mins": 6650930}], "institutional": [], "holdings": [], "directors": [], "status": {"status": "delisted", "exchange": null, "note": "No longer in the live ASX listing \u2014 delisted, acquired or merged. Historical filings are retained here; live price history ends at delisting."}, "corporate_actions": {"status_label": "", "items": []}, "key_people": [{"who": "Baker BROS. Advisors LP", "who_key": "BAKER BROS. ADVISORS LP", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "bought": 90922741.8815, "sold": 0, "net": 90922741.8815, "trades": 9, "top_score": 76.2, "lean": "buying", "history": [{"action": "BUY", "amount": 1115615.46, "date": "2019-08-07", "score": 51.9, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000163859919000703/0001638599-19-000703-index.htm"}, {"action": "BUY", "amount": 6836812.6597, "date": "2017-01-09", "score": 58.9, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000163859917000050/0001638599-17-000050-index.htm"}, {"action": "BUY", "amount": 34110452.485, "date": "2016-09-20", "score": 72.3, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000163859916001421/0001638599-16-001421-index.htm"}, {"action": "BUY", "amount": 3770636.3501000004, "date": "2016-03-16", "score": 55.8, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000163859916000744/0001638599-16-000744-index.htm"}, {"action": "BUY", "amount": 1520909.2058, "date": "2016-01-26", "score": 50.8, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000114420416077069/0001144204-16-077069-index.htm"}, {"action": "BUY", "amount": 1773653.4368999999, "date": "2016-01-20", "score": 51.6, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000114420416076372/0001144204-16-076372-index.htm"}, {"action": "BUY", "amount": 1677083.142, "date": "2016-01-15", "score": 51.4, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000114420416075875/0001144204-16-075875-index.htm"}, {"action": "BUY", "amount": 1677083.142, "date": "2016-01-15", "score": 51.4, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000114420416075880/0001144204-16-075880-index.htm"}, {"action": "BUY", "amount": 38440496.0, "date": "2015-09-10", "score": 76.2, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000114420415054640/0001144204-15-054640-index.htm"}], "latest": {"action": "BUY", "amount": 1115615.46, "date": "2019-08-07", "score": 51.9, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000163859919000703/0001638599-19-000703-index.htm"}}, {"who": "& Johnson Johnson", "who_key": "JOHNSON & JOHNSON", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "bought": 2999997.0, "sold": 34333506.67, "net": -31333509.67, "trades": 9, "top_score": 57.2, "lean": "selling", "history": [{"action": "SELL", "amount": 33944876.14, "date": "2015-08-11", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/200406/000090445415000512/0000904454-15-000512-index.htm"}, {"action": "SELL", "amount": 61723.35, "date": "2014-12-17", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/200406/000090445414000809/0000904454-14-000809-index.htm"}, {"action": "SELL", "amount": 37536.45, "date": "2014-12-12", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/200406/000090445414000805/0000904454-14-000805-index.htm"}, {"action": "SELL", "amount": 64040.0, "date": "2014-12-10", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/200406/000090445414000793/0000904454-14-000793-index.htm"}, {"action": "SELL", "amount": 123451.73, "date": "2014-12-05", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/200406/000090445414000787/0000904454-14-000787-index.htm"}, {"action": "SELL", "amount": 9048.0, "date": "2014-12-01", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/200406/000090445414000781/0000904454-14-000781-index.htm"}, {"action": "SELL", "amount": 15500.0, "date": "2014-11-26", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/200406/000090445414000779/0000904454-14-000779-index.htm"}, {"action": "SELL", "amount": 77331.0, "date": "2014-11-24", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/200406/000090445414000769/0000904454-14-000769-index.htm"}, {"action": "BUY", "amount": 2999997.0, "date": "2014-03-12", "score": 57.2, "source_url": "https://www.sec.gov/Archives/edgar/data/200406/000090445415000039/0000904454-15-000039-index.htm"}], "latest": {"action": "SELL", "amount": 33944876.14, "date": "2015-08-11", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/200406/000090445415000512/0000904454-15-000512-index.htm"}}, {"who": "Pfizer Inc", "who_key": "PFIZER INC", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "bought": 2999997.0, "sold": 6880295.424, "net": -3880298.4239999996, "trades": 2, "top_score": 58.5, "lean": "selling", "history": [{"action": "SELL", "amount": 6880295.424, "date": "2015-08-10", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000122520815016754/0001225208-15-016754-index.htm"}, {"action": "BUY", "amount": 2999997.0, "date": "2014-03-12", "score": 58.5, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919114020601/0001209191-14-020601-index.htm"}], "latest": {"action": "SELL", "amount": 6880295.424, "date": "2015-08-10", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000122520815016754/0001225208-15-016754-index.htm"}}, {"who": "Lloyd MacKenzie", "who_key": "MacKenzie Lloyd", "role": "Chief Operating Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "bought": 0, "sold": 689059.0708, "net": -689059.0708, "trades": 2, "top_score": 0, "lean": "selling", "history": [{"action": "SELL", "amount": 19048.7808, "date": "2018-03-15", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919118020680/0001209191-18-020680-index.htm"}, {"action": "SELL", "amount": 670010.29, "date": "2015-08-12", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919115066178/0001209191-15-066178-index.htm"}], "latest": {"action": "SELL", "amount": 19048.7808, "date": "2018-03-15", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919118020680/0001209191-18-020680-index.htm"}}, {"who": "Kamran Alam", "who_key": "Alam Kamran", "role": "CFO, Vice President Finance", "person_type": "C_SUITE", "person_label": "C-Suite", "bought": 0, "sold": 542904.93, "net": -542904.93, "trades": 1, "top_score": 0, "lean": "selling", "history": [{"action": "SELL", "amount": 542904.93, "date": "2015-08-12", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919115066176/0001209191-15-066176-index.htm"}], "latest": {"action": "SELL", "amount": 542904.93, "date": "2015-08-12", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919115066176/0001209191-15-066176-index.htm"}}, {"who": "David Main", "who_key": "Main David", "role": "President and CEO, Director", "person_type": "CEO", "person_label": "CEOs", "bought": 0, "sold": 207243.7375, "net": -207243.7375, "trades": 1, "top_score": 0, "lean": "selling", "history": [{"action": "SELL", "amount": 207243.7375, "date": "2017-06-05", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919117037966/0001209191-17-037966-index.htm"}], "latest": {"action": "SELL", "amount": 207243.7375, "date": "2017-06-05", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919117037966/0001209191-17-037966-index.htm"}}, {"who": "David Chilton Mitchell", "who_key": "Mitchell David Chilton", "role": "VP Global Regulatory & Quality", "person_type": "EXEC", "person_label": "Execs", "bought": 102646.75, "sold": 0, "net": 102646.75, "trades": 2, "top_score": 31.7, "lean": "buying", "history": [{"action": "BUY", "amount": 63670.74999999999, "date": "2015-08-24", "score": 31.7, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919115068028/0001209191-15-068028-index.htm"}, {"action": "BUY", "amount": 38976.0, "date": "2015-08-11", "score": 29.2, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919115065926/0001209191-15-065926-index.htm"}], "latest": {"action": "BUY", "amount": 63670.74999999999, "date": "2015-08-24", "score": 31.7, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919115068028/0001209191-15-068028-index.htm"}}, {"who": "Daniel J. Levitt", "who_key": "LEVITT DANIEL J", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 0, "sold": 49489.02, "net": -49489.02, "trades": 1, "top_score": 0, "lean": "selling", "history": [{"action": "SELL", "amount": 49489.02, "date": "2018-05-14", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919118030711/0001209191-18-030711-index.htm"}], "latest": {"action": "SELL", "amount": 49489.02, "date": "2018-05-14", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919118030711/0001209191-18-030711-index.htm"}}], "activity": [], "announcements": [{"form": "SCHEDULE 13G", "date": "2026-10-07", "title": "Form SCHEDULE 13G", "accession": "0001137774-26-000205", "price_sensitive": false}, {"form": "SCHEDULE 13G", "date": "2026-10-06", "title": "Form SCHEDULE 13G", "accession": "0000053417-26-000058", "price_sensitive": false}, {"form": "4", "date": "2026-10-02", "title": "FORM 4", "accession": "0001606302-26-000007", "price_sensitive": false}, {"form": "SCHEDULE 13G/A", "date": "2026-08-14", "title": "Form SCHEDULE 13G/A", "accession": "0001104659-26-097193", "price_sensitive": false}, {"form": "SCHEDULE 13G/A", "date": "2026-08-14", "title": "Form SCHEDULE 13G/A", "accession": "0001493152-26-038383", "price_sensitive": false}, {"form": "SCHEDULE 13G", "date": "2026-08-14", "title": "Form SCHEDULE 13G", "accession": "0001172661-26-003430", "price_sensitive": false}, {"form": "10-Q", "date": "2026-08-11", "title": "Quarterly report", "accession": "0001404644-26-000059", "price_sensitive": true}, {"form": "8-K", "date": "2026-08-11", "title": "Material event", "accession": "0001404644-26-000056", "price_sensitive": true}, {"form": "4", "date": "2026-07-07", "title": "FORM 4", "accession": "0001543663-26-000017", "price_sensitive": false}, {"form": "4", "date": "2026-07-02", "title": "FORM 4", "accession": "0001543663-26-000015", "price_sensitive": false}, {"form": "8-K", "date": "2026-07-02", "title": "Material event", "accession": "0001404644-26-000050", "price_sensitive": true}, {"form": "424B5", "date": "2026-07-02", "title": "Prospectus", "accession": "0001628280-26-046666", "price_sensitive": false}, {"form": "424B5", "date": "2026-06-30", "title": "Prospectus", "accession": "0001628280-26-046237", "price_sensitive": false}, {"form": "8-K", "date": "2026-06-29", "title": "Material event", "accession": "0001404644-26-000046", "price_sensitive": true}, {"form": "4/A", "date": "2026-06-16", "title": "FORM 4/A", "accession": "0001996804-26-000011", "price_sensitive": false}, {"form": "4/A", "date": "2026-06-16", "title": "FORM 4/A", "accession": "0001996804-26-000010", "price_sensitive": false}, {"form": "4/A", "date": "2026-06-16", "title": "FORM 4/A", "accession": "0001996804-26-000009", "price_sensitive": false}, {"form": "3/A", "date": "2026-06-16", "title": "FORM 3/A", "accession": "0001996804-26-000008", "price_sensitive": false}, {"form": "8-K", "date": "2026-06-08", "title": "Material event", "accession": "0001404644-26-000044", "price_sensitive": true}, {"form": "8-K", "date": "2026-06-04", "title": "Material event", "accession": "0001404644-26-000040", "price_sensitive": true}, {"form": "8-K", "date": "2026-05-12", "title": "Material event", "accession": "0001404644-26-000038", "price_sensitive": true}, {"form": "10-Q", "date": "2026-05-12", "title": "Quarterly report", "accession": "0001404644-26-000037", "price_sensitive": true}, {"form": "4", "date": "2026-05-08", "title": "FORM 4", "accession": "0001543663-26-000013", "price_sensitive": false}, {"form": "4", "date": "2026-05-07", "title": "FORM 4", "accession": "0001934412-26-000006", "price_sensitive": false}, {"form": "144", "date": "2026-05-06", "title": "Notice of proposed sale", "accession": "0001968582-26-000406", "price_sensitive": false}], "performance": {"ticker": "AQXP", "has_prices": false, "summary": null, "buys": [{"who": "BAKER BROS. ADVISORS LP", "person_type": "BOARD", "person_label": "Board", "role": "Director, 10% Owner", "amount": 1115615.46, "date": "2019-08-07", "score": 51.9, "ref_price": null, "return": null}, {"who": "BAKER BROS. ADVISORS LP", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 6836812.6597, "date": "2017-01-09", "score": 58.9, "ref_price": null, "return": null}, {"who": "BAKER BROS. ADVISORS LP", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 34110452.485, "date": "2016-09-20", "score": 72.3, "ref_price": null, "return": null}, {"who": "BAKER BROS. ADVISORS LP", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 3770636.3501000004, "date": "2016-03-16", "score": 55.8, "ref_price": null, "return": null}, {"who": "BAKER BROS. ADVISORS LP", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 1520909.2058, "date": "2016-01-26", "score": 50.8, "ref_price": null, "return": null}, {"who": "BAKER BROS. ADVISORS LP", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 1773653.4368999999, "date": "2016-01-20", "score": 51.6, "ref_price": null, "return": null}, {"who": "BAKER BROS. ADVISORS LP", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 1677083.142, "date": "2016-01-15", "score": 51.4, "ref_price": null, "return": null}, {"who": "BAKER BROS. ADVISORS LP", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 1677083.142, "date": "2016-01-15", "score": 51.4, "ref_price": null, "return": null}, {"who": "BAKER BROS. ADVISORS LP", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 38440496.0, "date": "2015-09-10", "score": 76.2, "ref_price": null, "return": null}, {"who": "Mitchell David Chilton", "person_type": "EXEC", "person_label": "Execs", "role": "VP Global Regulatory & Quality", "amount": 63670.74999999999, "date": "2015-08-24", "score": 31.7, "ref_price": null, "return": null}, {"who": "Mitchell David Chilton", "person_type": "EXEC", "person_label": "Execs", "role": "VP Global Regulatory & Quality", "amount": 38976.0, "date": "2015-08-11", "score": 29.2, "ref_price": null, "return": null}, {"who": "JOHNSON & JOHNSON", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 2999997.0, "date": "2014-03-12", "score": 57.2, "ref_price": null, "return": null}, {"who": "PFIZER INC", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 2999997.0, "date": "2014-03-12", "score": 58.5, "ref_price": null, "return": null}]}, "price_series": [], "refreshing": true}